POTASSIUM CHLORIDE

POTASSIUM CHLORIDE was reported 115163 times

POTASSIUM CHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VAGINAL FLATULENCE 184 0.6073
1 APPENDICOLITH 211 0.5452
2 SLEEP DISORDER THERAPY 103 0.5202
3 ANALGESIC THERAPY 100 0.3115
4 DRUG THERAPY 93 0.2743
5 DEVICE MAINTENANCE ISSUE 98 0.1667
6 FEMALE GENITAL TRACT FISTULA 206 0.1205
7 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 109 0.1026
8 RADICULOPATHY 254 0.0963
9 HYPERPARATHYROIDISM SECONDARY 219 0.0873
10 INFUSION SITE DISCHARGE 150 0.0855
11 NEPHROGENIC ANAEMIA 392 0.0845
12 HYPERPHOSPHATAEMIA 177 0.0822
13 CARDIOACTIVE DRUG LEVEL INCREASED 108 0.0821
14 CHRONIC SINUSITIS 279 0.0743
15 LEFT ATRIAL DILATATION 93 0.0729
16 ESSENTIAL HYPERTENSION 133 0.0726
17 PROCTITIS 202 0.0720
18 OESOPHAGEAL SPASM 123 0.0667
19 INFUSION SITE INFECTION 155 0.0666
20 BLOOD PHOSPHORUS INCREASED 179 0.0655
21 ORTHOPNOEA 198 0.0621
22 OBSTRUCTIVE SLEEP APNOEA SYNDROME 88 0.0603
23 HYPERVOLAEMIA 297 0.0600
24 INFUSION SITE HAEMORRHAGE 197 0.0598
25 METABOLIC ALKALOSIS 96 0.0598
26 DEVICE INFUSION ISSUE 144 0.0580
27 HAEMORRHAGIC ANAEMIA 247 0.0561
28 AORTIC STENOSIS 195 0.0559
29 REBOUND ACID HYPERSECRETION 163 0.0538
30 THERAPEUTIC AGENT TOXICITY 178 0.0533
31 OXYGEN CONSUMPTION INCREASED 125 0.0523
32 ISCHAEMIC CARDIOMYOPATHY 157 0.0512
33 BLOOD CHLORIDE DECREASED 130 0.0504
34 RIGHT VENTRICULAR FAILURE 341 0.0486
35 HYPOKALAEMIA 2244 0.0486
36 BRAIN NATRIURETIC PEPTIDE INCREASED 148 0.0480
37 INFUSION SITE PAIN 613 0.0475
38 BLOOD POTASSIUM DECREASED 1399 0.0465
39 VASCULAR DEVICE INFECTION 208 0.0458
40 LYMPHOEDEMA 317 0.0458
41 COLITIS MICROSCOPIC 215 0.0453
42 INFUSION SITE ERYTHEMA 381 0.0451
43 INFUSION SITE SWELLING 282 0.0448
44 CATHETER SITE HAEMORRHAGE 110 0.0439
45 CATHETER SITE ERYTHEMA 94 0.0439
46 ATELECTASIS 424 0.0438
47 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 218 0.0430
48 BREATH SOUNDS ABNORMAL 212 0.0429
49 PULMONARY HYPERTENSION 894 0.0429
50 RALES 241 0.0415
51 MITRAL VALVE INCOMPETENCE 468 0.0413
52 METABOLIC ENCEPHALOPATHY 122 0.0406
53 BLOOD LOSS ANAEMIA 92 0.0406
54 HYPOPHOSPHATAEMIA 297 0.0401
55 CARDIOMEGALY 494 0.0401
56 TRICUSPID VALVE INCOMPETENCE 319 0.0401
57 HYPOVOLAEMIA 234 0.0400
58 MULTIPLE INJURIES 250 0.0397
59 INFUSION SITE REACTION 118 0.0395
60 HAEMOGLOBIN INCREASED 180 0.0394
61 ATRIAL FLUTTER 310 0.0388
62 ATRIOVENTRICULAR BLOCK FIRST DEGREE 167 0.0385
63 HYPERLIPIDAEMIA 460 0.0385
64 VENTRICULAR FIBRILLATION 422 0.0380
65 END STAGE RENAL DISEASE 692 0.0379
66 SUPRAVENTRICULAR EXTRASYSTOLES 128 0.0379
67 MACULAR DEGENERATION 451 0.0377
68 ACUTE RESPIRATORY FAILURE 723 0.0375
69 DIASTOLIC DYSFUNCTION 116 0.0375
70 BLOOD MAGNESIUM DECREASED 317 0.0367
71 SEASONAL ALLERGY 518 0.0366
72 LOWER GASTROINTESTINAL HAEMORRHAGE 268 0.0362
73 IRON DEFICIENCY 163 0.0362
74 LEFT VENTRICULAR FAILURE 124 0.0360
75 PLEURITIC PAIN 98 0.0355
76 LEFT VENTRICULAR HYPERTROPHY 151 0.0352
77 BLOOD POTASSIUM ABNORMAL 94 0.0352
78 OESOPHAGEAL PAIN 139 0.0351
79 AORTIC VALVE INCOMPETENCE 149 0.0350
80 CARDIOGENIC SHOCK 502 0.0350
81 FLUID OVERLOAD 508 0.0349
82 HYPERKALAEMIA 1223 0.0348
83 AORTIC ARTERIOSCLEROSIS 89 0.0345
84 PROTHROMBIN TIME PROLONGED 205 0.0342
85 INFUSION SITE PRURITUS 106 0.0336
86 ECONOMIC PROBLEM 509 0.0336
87 FAILURE TO THRIVE 174 0.0335
88 CARDIAC FAILURE CONGESTIVE 2687 0.0334
89 BLOOD URIC ACID INCREASED 193 0.0334
90 BUNDLE BRANCH BLOCK LEFT 140 0.0330
91 LUNG CONSOLIDATION 91 0.0325
92 HYPOMAGNESAEMIA 451 0.0324
93 PULMONARY ARTERIAL HYPERTENSION 466 0.0321
94 ARTERIOSCLEROSIS CORONARY ARTERY 212 0.0320
95 CLOSTRIDIUM DIFFICILE COLITIS 328 0.0309
96 HYPERCAPNIA 93 0.0308
97 CARDIAC MURMUR 266 0.0307
98 ELECTROLYTE IMBALANCE 357 0.0307
99 RENAL FAILURE CHRONIC 236 0.0307
100 FLUID RETENTION 1555 0.0305
101 INTERNATIONAL NORMALISED RATIO DECREASED 123 0.0303
102 DYSPNOEA EXERTIONAL 1140 0.0302
103 BENIGN PROSTATIC HYPERPLASIA 156 0.0302
104 DIVERTICULUM 214 0.0301
105 APPENDICITIS 279 0.0298
106 PERIPHERAL VASCULAR DISORDER 153 0.0297
107 CHEST X-RAY ABNORMAL 91 0.0297
108 LUNG INFILTRATION 261 0.0295
109 CAROTID ARTERY STENOSIS 102 0.0292
110 BLOOD UREA INCREASED 489 0.0292
111 IRON DEFICIENCY ANAEMIA 265 0.0287
112 CARDIAC FAILURE CHRONIC 122 0.0286
113 TROPONIN INCREASED 217 0.0285
114 BLOOD ALBUMIN DECREASED 226 0.0285
115 CHRONIC KIDNEY DISEASE 2134 0.0281
116 GOUT 503 0.0280
117 HYPERNATRAEMIA 139 0.0279
118 LEFT VENTRICULAR DYSFUNCTION 186 0.0277
119 ORAL CANDIDIASIS 364 0.0276
120 MULTIPLE ALLERGIES 216 0.0275
121 CATHETERISATION CARDIAC 122 0.0275
122 MYASTHENIA GRAVIS 222 0.0275
123 HYPOXIA 963 0.0273
124 ASCITES 801 0.0272
125 CONGESTIVE CARDIOMYOPATHY 113 0.0271
126 ATRIAL FIBRILLATION 2621 0.0269
127 PEPTIC ULCER 89 0.0268
128 DERMATITIS CONTACT 305 0.0267
129 INTERNATIONAL NORMALISED RATIO INCREASED 759 0.0266
130 PROTEIN TOTAL DECREASED 100 0.0265
131 SLEEP APNOEA SYNDROME 505 0.0264
132 VENTRICULAR EXTRASYSTOLES 273 0.0263
133 CARDIAC FAILURE ACUTE 175 0.0262
134 ELECTROCARDIOGRAM ABNORMAL 205 0.0261
135 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1363 0.0261
136 UPPER GASTROINTESTINAL HAEMORRHAGE 439 0.0261
137 VENTRICULAR TACHYCARDIA 426 0.0258
138 RENAL FAILURE ACUTE 1085 0.0255
139 DIVERTICULUM INTESTINAL 111 0.0254
140 CATHETER SITE INFECTION 96 0.0254
141 CARDIAC VALVE DISEASE 145 0.0253
142 CARDIOMYOPATHY 374 0.0253
143 RED CELL DISTRIBUTION WIDTH INCREASED 105 0.0252
144 PULSE ABSENT 119 0.0250
145 OEDEMA PERIPHERAL 3049 0.0250
146 HIATUS HERNIA 323 0.0249
147 EXERCISE TOLERANCE DECREASED 143 0.0248
148 MALNUTRITION 277 0.0247
149 GASTROINTESTINAL HAEMORRHAGE 2055 0.0246
150 CYTOKINE RELEASE SYNDROME 492 0.0245
151 HAEMORRHOIDAL HAEMORRHAGE 119 0.0243
152 GENERALISED OEDEMA 301 0.0243
153 AZOTAEMIA 97 0.0243
154 DIABETIC NEUROPATHY 120 0.0242
155 PNEUMONIA ASPIRATION 600 0.0240
156 HEPARIN-INDUCED THROMBOCYTOPENIA 118 0.0239
157 SPINAL OSTEOARTHRITIS 210 0.0239
158 COAGULOPATHY 398 0.0239
159 HYPOALBUMINAEMIA 185 0.0238
160 PLEURAL EFFUSION 1446 0.0237
161 HAEMATOCRIT DECREASED 468 0.0236
162 TOXIC EPIDERMAL NECROLYSIS 358 0.0236
163 ARTERIOSCLEROSIS 220 0.0234
164 BLOOD POTASSIUM INCREASED 378 0.0233
165 BUNDLE BRANCH BLOCK RIGHT 106 0.0231
166 MENTAL STATUS CHANGES 636 0.0229
167 EMPHYSEMA 229 0.0227
168 CANDIDIASIS 91 0.0227
169 HOSPICE CARE 224 0.0227
170 PURULENT DISCHARGE 96 0.0225
171 DYSLIPIDAEMIA 114 0.0224
172 PRODUCT RESIDUE PRESENT 121 0.0224
173 BLOOD CREATINE INCREASED 99 0.0223
174 RENAL TUBULAR NECROSIS 219 0.0223
175 ACUTE KIDNEY INJURY 3403 0.0222
176 DECUBITUS ULCER 181 0.0222
177 PERICARDIAL EFFUSION 501 0.0216
178 OEDEMA 1175 0.0216
179 RENAL CYST 172 0.0216
180 TRANSFUSION 226 0.0215
181 MULTIPLE MYELOMA 100 0.0214
182 CELLULITIS 1073 0.0213
183 SUPRAVENTRICULAR TACHYCARDIA 203 0.0212
184 HYPERURICAEMIA 87 0.0211
185 HYPONATRAEMIA 1189 0.0211
186 PAIN IN JAW 597 0.0211
187 BACTERAEMIA 250 0.0210
188 BODY HEIGHT DECREASED 225 0.0210
189 INTERVERTEBRAL DISC DEGENERATION 194 0.0209
190 SMALL INTESTINAL OBSTRUCTION 258 0.0209
191 STAPHYLOCOCCAL BACTERAEMIA 91 0.0209
192 COMPRESSION FRACTURE 112 0.0209
193 RENAL FAILURE 2773 0.0209
194 ESCHERICHIA URINARY TRACT INFECTION 88 0.0207
195 CARDIAC PACEMAKER INSERTION 123 0.0206
196 LEUKOCYTOSIS 373 0.0206
197 RECTAL HAEMORRHAGE 884 0.0206
198 CORONARY ARTERY DISEASE 619 0.0204
199 SEPSIS 2278 0.0204
200 AMMONIA INCREASED 104 0.0204
201 PARAESTHESIA ORAL 294 0.0204
202 OXYGEN SATURATION DECREASED 1144 0.0203
203 BACTERIAL INFECTION 379 0.0203
204 ECCHYMOSIS 139 0.0203
205 ORTHOSTATIC HYPOTENSION 353 0.0203
206 DIVERTICULITIS 560 0.0202
207 PULMONARY OEDEMA 904 0.0202
208 UROSEPSIS 186 0.0201
209 RESPIRATORY FAILURE 1465 0.0201
210 BRONCHITIS 1480 0.0200
211 GASTRITIS EROSIVE 93 0.0199
212 SPINAL COLUMN STENOSIS 94 0.0199
213 DEHYDRATION 2636 0.0197
214 VAGINAL DISCHARGE 199 0.0196
215 EJECTION FRACTION DECREASED 305 0.0196
216 ANAEMIA 3739 0.0196
217 FEBRILE NEUTROPENIA 1296 0.0195
218 OESOPHAGITIS 212 0.0194
219 CYSTITIS 613 0.0192
220 ABDOMINAL TENDERNESS 95 0.0191
221 CORONARY ARTERY STENOSIS 96 0.0191
222 DIZZINESS POSTURAL 185 0.0191
223 RENAL INJURY 564 0.0190
224 SCOLIOSIS 117 0.0189
225 URINE OUTPUT DECREASED 165 0.0189
226 ABDOMINAL HERNIA 86 0.0188
227 HYPERCHOLESTEROLAEMIA 182 0.0188
228 SHOCK HAEMORRHAGIC 153 0.0188
229 HYDRONEPHROSIS 140 0.0187
230 BLOOD PRESSURE SYSTOLIC DECREASED 85 0.0187
231 BLOOD SODIUM DECREASED 350 0.0185
232 BLOOD CALCIUM INCREASED 162 0.0185
233 HUMERUS FRACTURE 89 0.0184
234 SINUS BRADYCARDIA 178 0.0184
235 FULL BLOOD COUNT DECREASED 371 0.0184
236 SEPTIC SHOCK 801 0.0184
237 VITAMIN D DEFICIENCY 179 0.0183
238 HYPOCALCAEMIA 347 0.0183
239 FAECAL INCONTINENCE 88 0.0183
240 GASTROOESOPHAGEAL REFLUX DISEASE 1465 0.0182
241 HYPOTENSION 3650 0.0182
242 ACUTE PULMONARY OEDEMA 102 0.0182
243 HAEMORRHOIDS 354 0.0181
244 OBESITY 289 0.0181
245 BLOOD ALKALINE PHOSPHATASE INCREASED 450 0.0181
246 TACHYPNOEA 246 0.0181
247 GLAUCOMA 348 0.0181
248 PULMONARY CONGESTION 238 0.0180
249 HAEMOPTYSIS 503 0.0180
250 ENTEROCOCCAL INFECTION 87 0.0180
251 CARDIAC FAILURE 1431 0.0178
252 SKIN LACERATION 192 0.0176
253 STAPHYLOCOCCAL SEPSIS 87 0.0176
254 ULCER 280 0.0176
255 PULMONARY MASS 262 0.0176
256 BLOOD BILIRUBIN INCREASED 475 0.0176
257 BLOOD CALCIUM DECREASED 197 0.0175
258 MULTIPLE ORGAN DYSFUNCTION SYNDROME 496 0.0175
259 HEART RATE IRREGULAR 395 0.0175
260 MULTI-ORGAN FAILURE 302 0.0175
261 INCREASED TENDENCY TO BRUISE 160 0.0174
262 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 103 0.0174
263 DEVICE RELATED INFECTION 267 0.0173
264 INTERNAL HAEMORRHAGE 198 0.0173
265 PRODUCTIVE COUGH 826 0.0173
266 EPISTAXIS 1285 0.0172
267 SINUS TACHYCARDIA 243 0.0171
268 HEPATIC CYTOLYSIS 218 0.0171
269 VARICOSE VEIN 88 0.0170
270 PNEUMONIA 5515 0.0170
271 COLITIS 643 0.0169
272 EXTRASYSTOLES 118 0.0169
273 ADRENAL INSUFFICIENCY 205 0.0169
274 INTESTINAL ISCHAEMIA 93 0.0169
275 RESPIRATORY DISTRESS 466 0.0169
276 BLOOD IRON DECREASED 200 0.0168
277 SPINAL COMPRESSION FRACTURE 139 0.0168
278 PANCYTOPENIA 938 0.0168
279 HYPERCALCAEMIA 206 0.0167
280 ILEUS 206 0.0166
281 PSYCHOLOGICAL TRAUMA 143 0.0166
282 SPUTUM DISCOLOURED 157 0.0165
283 CHOLECYSTITIS ACUTE 93 0.0164
284 BLOOD CREATININE INCREASED 1071 0.0164
285 HAEMORRHAGIC STROKE 128 0.0164
286 SUBDURAL HAEMATOMA 233 0.0163
287 PNEUMONIA BACTERIAL 149 0.0162
288 UPPER-AIRWAY COUGH SYNDROME 133 0.0161
289 ANHEDONIA 423 0.0161
290 ENCEPHALOPATHY 394 0.0160
291 HAEMOGLOBIN DECREASED 1645 0.0160
292 ANGINA UNSTABLE 104 0.0160
293 LYMPHOCYTE COUNT DECREASED 282 0.0159
294 RED BLOOD CELL COUNT DECREASED 456 0.0159
295 PRODUCT ADMINISTRATION INTERRUPTED 125 0.0159
296 TRANSIENT ISCHAEMIC ATTACK 537 0.0159
297 UPPER RESPIRATORY TRACT INFECTION 733 0.0158
298 HAEMATOMA 411 0.0158
299 TORSADE DE POINTES 124 0.0158
300 COVID-19 PNEUMONIA 186 0.0157
301 SINUS CONGESTION 212 0.0157
302 MELAENA 344 0.0156
303 CARDIAC FLUTTER 101 0.0156
304 WEIGHT FLUCTUATION 163 0.0156
305 HAIR DISORDER 128 0.0155
306 NEPHROPATHY 145 0.0155
307 POLYURIA 127 0.0155
308 ESCHERICHIA INFECTION 127 0.0154
309 HEPATIC ENCEPHALOPATHY 144 0.0154
310 NEUTROPENIC SEPSIS 110 0.0154
311 PRE-EXISTING CONDITION IMPROVED 96 0.0154
312 RIB FRACTURE 316 0.0153
313 URINARY TRACT INFECTION 2619 0.0153
314 ASPIRATION 168 0.0153
315 LARGE INTESTINE POLYP 106 0.0153
316 HEAD INJURY 484 0.0153
317 HEART RATE ABNORMAL 85 0.0152
318 TUMOUR LYSIS SYNDROME 134 0.0152
319 CATARACT OPERATION 90 0.0152
320 CLOSTRIDIUM DIFFICILE INFECTION 330 0.0151
321 CHOLELITHIASIS 495 0.0151
322 RESPIRATORY TRACT CONGESTION 238 0.0150
323 BRADYCARDIA 793 0.0149
324 BLOOD TEST ABNORMAL 210 0.0149
325 ATRIOVENTRICULAR BLOCK COMPLETE 100 0.0149
326 GASTROENTERITIS 218 0.0149
327 PRESYNCOPE 363 0.0149
328 PLATELET COUNT DECREASED 1588 0.0149
329 SINUS DISORDER 294 0.0148
330 COLITIS ISCHAEMIC 100 0.0148
331 ACUTE MYOCARDIAL INFARCTION 437 0.0148
332 NEURALGIA 359 0.0147
333 FULL BLOOD COUNT ABNORMAL 156 0.0147
334 CORONARY ARTERY OCCLUSION 202 0.0147
335 REFUSAL OF TREATMENT BY PATIENT 96 0.0147
336 DYSPNOEA 8319 0.0147
337 MYOCARDIAL ISCHAEMIA 167 0.0147
338 POLYP 96 0.0146
339 DEEP VEIN THROMBOSIS 951 0.0146
340 ATRIOVENTRICULAR BLOCK 112 0.0145
341 HEPATIC CIRRHOSIS 272 0.0145
342 PSEUDOMONAS INFECTION 124 0.0144
343 CARDIAC ARREST 1189 0.0144
344 PELVIC FRACTURE 112 0.0144
345 FIBROMYALGIA 349 0.0143
346 LACERATION 135 0.0143
347 CONSTIPATION 3128 0.0143
348 TENDERNESS 149 0.0143
349 STAPHYLOCOCCAL INFECTION 471 0.0143
350 BRONCHIECTASIS 96 0.0142
351 DEMENTIA 397 0.0142
352 TUBULOINTERSTITIAL NEPHRITIS 266 0.0142
353 CHOLECYSTITIS 169 0.0142
354 WALKING AID USER 93 0.0141
355 WRIST FRACTURE 169 0.0141
356 NOCTURIA 171 0.0141
357 FLANK PAIN 132 0.0141
358 FALL 4686 0.0141
359 UNRESPONSIVE TO STIMULI 363 0.0141
360 APPETITE DISORDER 93 0.0140
361 HYPERBILIRUBINAEMIA 145 0.0140
362 BLOOD PRESSURE DECREASED 930 0.0140
363 SYNCOPE 1397 0.0139
364 ABDOMINAL DISTENSION 1456 0.0139
365 AORTIC ANEURYSM 106 0.0139
366 NERVE COMPRESSION 128 0.0139
367 HAEMODIALYSIS 116 0.0138
368 PERIPHERAL SWELLING 2125 0.0138
369 LUNG INFECTION 214 0.0138
370 NEUTROPHIL COUNT INCREASED 141 0.0138
371 GLOMERULAR FILTRATION RATE DECREASED 169 0.0137
372 HYPERGLYCAEMIA 501 0.0137
373 C-REACTIVE PROTEIN INCREASED 499 0.0137
374 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 235 0.0137
375 ASPARTATE AMINOTRANSFERASE INCREASED 728 0.0137
376 ASTHENIA 5151 0.0137
377 SCIATICA 218 0.0137
378 SPLENOMEGALY 160 0.0136
379 LIGAMENT SPRAIN 135 0.0136
380 PLASMA CELL MYELOMA 532 0.0136
381 MUSCULOSKELETAL CHEST PAIN 211 0.0136
382 THYROID DISORDER 210 0.0136
383 CANDIDA INFECTION 230 0.0136
384 HYPOPHAGIA 348 0.0136
385 OSTEOARTHRITIS 577 0.0136
386 HAEMATURIA 466 0.0136
387 CHEST PAIN 2518 0.0136
388 LABORATORY TEST ABNORMAL 401 0.0136
389 PULMONARY THROMBOSIS 148 0.0136
390 IMPAIRED GASTRIC EMPTYING 185 0.0136
391 NEUROPATHY PERIPHERAL 1288 0.0135
392 DEVICE OCCLUSION 190 0.0135
393 JOINT EFFUSION 93 0.0135
394 GASTRITIS 354 0.0134
395 HEPATOMEGALY 132 0.0134
396 PETECHIAE 140 0.0134
397 LOCALISED INFECTION 324 0.0134
398 INCONTINENCE 141 0.0133
399 THROMBOCYTOPENIA 1489 0.0133
400 CONTUSION 1278 0.0133
401 WEIGHT DECREASED 3687 0.0132
402 PYELONEPHRITIS 114 0.0131
403 MICTURITION URGENCY 150 0.0131
404 PROCEDURAL PAIN 364 0.0131
405 OSTEOPENIA 199 0.0131
406 HAIR COLOUR CHANGES 163 0.0131
407 RESPIRATORY SYNCYTIAL VIRUS INFECTION 114 0.0131
408 FREQUENT BOWEL MOVEMENTS 353 0.0131
409 DIABETES MELLITUS INADEQUATE CONTROL 231 0.0130
410 RESTLESS LEGS SYNDROME 237 0.0130
411 ARRHYTHMIA 617 0.0130
412 JOINT INJURY 278 0.0130
413 ROTATOR CUFF SYNDROME 167 0.0130
414 DIARRHOEA 8391 0.0130
415 SYNOVITIS 234 0.0130
416 MOUTH HAEMORRHAGE 95 0.0129
417 SKIN ULCER 334 0.0129
418 COMA 615 0.0129
419 TASTE DISORDER 260 0.0128
420 THROMBOSIS 1031 0.0128
421 HYPOTHYROIDISM 409 0.0128
422 PULMONARY HAEMORRHAGE 100 0.0128
423 SUBARACHNOID HAEMORRHAGE 130 0.0128
424 GROIN PAIN 112 0.0127
425 PULMONARY EMBOLISM 1210 0.0127
426 HAEMATOCHEZIA 702 0.0127
427 WHITE BLOOD CELL COUNT INCREASED 488 0.0127
428 WOUND INFECTION 139 0.0127
429 HEPATIC STEATOSIS 235 0.0126
430 DYSURIA 464 0.0126
431 INTERVERTEBRAL DISC PROTRUSION 275 0.0126
432 GASTRIC ULCER 239 0.0126
433 DECREASED APPETITE 2885 0.0124
434 COUGH 3481 0.0124
435 HYPOGLYCAEMIA 601 0.0124
436 RESPIRATORY RATE INCREASED 110 0.0124
437 MYOPATHY 107 0.0124
438 BLOOD PRESSURE ABNORMAL 246 0.0124
439 WHITE BLOOD CELL COUNT DECREASED 1341 0.0124
440 RESPIRATION ABNORMAL 85 0.0123
441 KIDNEY INFECTION 242 0.0123
442 NASAL CONGESTION 723 0.0123
443 OSTEOPOROSIS 505 0.0123
444 EXOSTOSIS 112 0.0123
445 GASTROENTERITIS VIRAL 221 0.0122
446 ELECTROCARDIOGRAM QT PROLONGED 440 0.0122
447 PARKINSONISM 119 0.0122
448 DENTAL CARIES 135 0.0122
449 BURSITIS 148 0.0122
450 LIMB INJURY 331 0.0122
451 HAIR TEXTURE ABNORMAL 163 0.0122
452 NEUTROPHIL COUNT DECREASED 496 0.0122
453 ABDOMINAL PAIN 2830 0.0122
454 ORAL PAIN 271 0.0121
455 URINARY INCONTINENCE 357 0.0120
456 MUSCLE STRAIN 104 0.0120
457 CARDIO-RESPIRATORY ARREST 501 0.0120
458 RETCHING 255 0.0119
459 VITAMIN D DECREASED 102 0.0119
460 STENT PLACEMENT 96 0.0119
461 BLADDER DISORDER 118 0.0119
462 RESPIRATORY TRACT INFECTION 309 0.0119
463 SINUSITIS 1215 0.0118
464 BLOOD URINE PRESENT 225 0.0118
465 ANKLE FRACTURE 183 0.0118
466 HERNIA 228 0.0118
467 DECREASED ACTIVITY 127 0.0118
468 HAEMORRHAGE INTRACRANIAL 176 0.0118
469 POST PROCEDURAL HAEMORRHAGE 137 0.0118
470 ACUTE RESPIRATORY DISTRESS SYNDROME 208 0.0117
471 DIABETES MELLITUS 895 0.0117
472 ANOREXIA 151 0.0117
473 FAECES DISCOLOURED 254 0.0117
474 TACHYCARDIA 1039 0.0117
475 BACK DISORDER 190 0.0117
476 OSTEOMYELITIS 211 0.0116
477 FACIAL PAIN 104 0.0116
478 HIP FRACTURE 374 0.0116
479 BACK PAIN 2699 0.0116
480 ALANINE AMINOTRANSFERASE INCREASED 713 0.0116
481 BLOOD DISORDER 93 0.0116
482 TOOTH ABSCESS 118 0.0116
483 MUSCULOSKELETAL PAIN 607 0.0116
484 ANAL INCONTINENCE 104 0.0116
485 POST PROCEDURAL COMPLICATION 222 0.0115
486 PNEUMOTHORAX 183 0.0115
487 STOMATITIS 699 0.0115
488 LUNG DISORDER 564 0.0115
489 PNEUMONITIS 313 0.0115
490 CHEST DISCOMFORT 1177 0.0115
491 BOWEL MOVEMENT IRREGULARITY 88 0.0115
492 ACUTE MYELOID LEUKAEMIA 179 0.0115
493 CIRCULATORY COLLAPSE 195 0.0114
494 DYSPEPSIA 1121 0.0114
495 WHEEZING 675 0.0114
496 CYANOSIS 179 0.0114
497 GALLBLADDER DISORDER 203 0.0114
498 HEART RATE DECREASED 399 0.0114
499 URINARY RETENTION 379 0.0113
500 BLOOD PRESSURE SYSTOLIC INCREASED 221 0.0113
501 EMBOLISM 94 0.0113
502 MOTOR DYSFUNCTION 115 0.0113
503 CARPAL TUNNEL SYNDROME 158 0.0113
504 BLOOD COUNT ABNORMAL 171 0.0113
505 FOOT FRACTURE 213 0.0112
506 SWELLING 1050 0.0112
507 NECK PAIN 626 0.0112
508 HYPERSOMNIA 321 0.0112
509 GINGIVAL PAIN 89 0.0112
510 HYPERTENSION 2348 0.0111
511 HEART RATE INCREASED 1096 0.0111
512 ATAXIA 131 0.0110
513 ABSCESS 176 0.0110
514 MUSCULAR WEAKNESS 1253 0.0110
515 CARDIAC DISORDER 1031 0.0110
516 INITIAL INSOMNIA 113 0.0110
517 INJURY 772 0.0110
518 BALANCE DISORDER 949 0.0110
519 DRY MOUTH 885 0.0109
520 CATARACT 649 0.0109
521 BLOOD THYROID STIMULATING HORMONE INCREASED 100 0.0109
522 DISSEMINATED INTRAVASCULAR COAGULATION 153 0.0109
523 MUSCULOSKELETAL DISCOMFORT 187 0.0109
524 PURPURA 96 0.0108
525 CONFUSIONAL STATE 1752 0.0108
526 RENAL DISORDER 505 0.0108
527 GENERAL PHYSICAL HEALTH DETERIORATION 1247 0.0108
528 LETHARGY 620 0.0108
529 GINGIVAL BLEEDING 147 0.0108
530 BONE DISORDER 196 0.0107
531 ABASIA 264 0.0107
532 BLOOD CHOLESTEROL INCREASED 498 0.0107
533 SPINAL FRACTURE 214 0.0107
534 HEREDITARY ANGIOEDEMA 114 0.0106
535 TYPE 2 DIABETES MELLITUS 357 0.0106
536 NEPHROLITHIASIS 485 0.0106
537 VOMITING 4967 0.0106
538 UNEVALUABLE EVENT 799 0.0105
539 UPPER LIMB FRACTURE 210 0.0105
540 PRODUCT USE COMPLAINT 166 0.0105
541 OROPHARYNGEAL DISCOMFORT 95 0.0105
542 SKIN REACTION 148 0.0105
543 GASTROINTESTINAL INFECTION 94 0.0105
544 PALPITATIONS 1226 0.0105
545 IMMUNODEFICIENCY 156 0.0105
546 PANCREATITIS ACUTE 235 0.0104
547 MASS 146 0.0104
548 HYPERTHYROIDISM 151 0.0104
549 METABOLIC ACIDOSIS 333 0.0104
550 THROAT IRRITATION 467 0.0104
551 HALLUCINATION 783 0.0104
552 HAEMOLYTIC ANAEMIA 93 0.0104
553 IMPAIRED QUALITY OF LIFE 149 0.0104
554 HEPATIC FAILURE 312 0.0103
555 BEDRIDDEN 136 0.0103
556 RENAL IMPAIRMENT 869 0.0103
557 HEMIPARESIS 175 0.0103
558 FATIGUE 8037 0.0103
559 FEEDING DISORDER 209 0.0103
560 SQUAMOUS CELL CARCINOMA 97 0.0103
561 CYTOPENIA 126 0.0103
562 PYREXIA 3558 0.0103
563 DYSPHONIA 601 0.0103
564 TEMPERATURE INTOLERANCE 106 0.0103
565 ACUTE CORONARY SYNDROME 85 0.0103
566 NERVE INJURY 114 0.0102
567 BLOOD TRIGLYCERIDES INCREASED 181 0.0102
568 PRODUCT DISTRIBUTION ISSUE 95 0.0102
569 ARTHRITIS 804 0.0102
570 DYSPHAGIA 970 0.0102
571 POLLAKIURIA 426 0.0102
572 FUNGAL INFECTION 340 0.0102
573 ANGINA PECTORIS 292 0.0102
574 FLUSHING 1035 0.0102
575 HAEMATEMESIS 258 0.0102
576 TOOTH INFECTION 134 0.0102
577 NAUSEA 8045 0.0102
578 LIVER FUNCTION TEST ABNORMAL 295 0.0101
579 SECRETION DISCHARGE 127 0.0101
580 JOINT DISLOCATION 107 0.0101
581 DIZZINESS 5044 0.0101
582 MADAROSIS 117 0.0101
583 TOOTH FRACTURE 111 0.0101
584 SHOCK 231 0.0100
585 FEAR 270 0.0100
586 FLATULENCE 568 0.0100
587 VIRAL INFECTION 333 0.0100
588 PAIN IN EXTREMITY 2947 0.0100
589 DRUG INTERACTION 1585 0.0100
590 THERAPY NON-RESPONDER 449 0.0100
591 LIVER FUNCTION TEST INCREASED 213 0.0099
592 DISEASE PROGRESSION 1172 0.0099
593 ACTIVITIES OF DAILY LIVING IMPAIRED 196 0.0099
594 INSURANCE ISSUE 151 0.0099
595 INTESTINAL OBSTRUCTION 372 0.0099
596 NEUTROPENIA 1340 0.0098
597 AGRANULOCYTOSIS 183 0.0098
598 MUSCLE SPASMS 1806 0.0098
599 EYE INFECTION 111 0.0098
600 PERITONITIS BACTERIAL 99 0.0098
601 MUSCLE ATROPHY 124 0.0098
602 MUCOSAL INFLAMMATION 256 0.0098
603 MOUTH ULCERATION 206 0.0098
604 BLOOD PRESSURE INCREASED 1494 0.0098
605 CHILLS 1141 0.0097
606 DYSARTHRIA 366 0.0097
607 SOMNOLENCE 1956 0.0097
608 GAMMA-GLUTAMYLTRANSFERASE INCREASED 215 0.0097
609 EAR DISCOMFORT 99 0.0096
610 PULMONARY FIBROSIS 185 0.0096
611 MYELODYSPLASTIC SYNDROME 139 0.0096
612 BLOOD LACTATE DEHYDROGENASE INCREASED 152 0.0096
613 LACTIC ACIDOSIS 310 0.0096
614 INFLUENZA 1067 0.0096
615 SKIN INFECTION 107 0.0095
616 WEIGHT INCREASED 2135 0.0095
617 RASH MACULO-PAPULAR 212 0.0095
618 EAR PAIN 184 0.0095
619 RESPIRATORY DISORDER 283 0.0095
620 EAR INFECTION 251 0.0094
621 CHOLESTASIS 181 0.0094
622 RED BLOOD CELL SEDIMENTATION RATE INCREASED 104 0.0094
623 DELIRIUM 326 0.0094
624 FEELING COLD 261 0.0094
625 APHASIA 283 0.0094
626 INFUSION RELATED REACTION 621 0.0094
627 PROSTATIC SPECIFIC ANTIGEN INCREASED 129 0.0094
628 CEREBRAL HAEMORRHAGE 334 0.0093
629 MYOCARDIAL INFARCTION 1625 0.0093
630 TOOTHACHE 168 0.0093
631 BODY TEMPERATURE INCREASED 189 0.0093
632 AGEUSIA 230 0.0092
633 DEVICE FAILURE 140 0.0092
634 HERPES ZOSTER 528 0.0092
635 SKIN LESION 252 0.0092
636 GAIT DISTURBANCE 1757 0.0092
637 LOCAL SWELLING 160 0.0092
638 HYPOKINESIA 133 0.0092
639 LOWER LIMB FRACTURE 176 0.0092
640 BONE MARROW FAILURE 186 0.0091
641 DYSSTASIA 267 0.0091
642 COLD SWEAT 161 0.0091
643 TOOTH DISORDER 203 0.0091
644 RESPIRATORY ARREST 251 0.0091
645 RHINORRHOEA 588 0.0091
646 LOSS OF CONSCIOUSNESS 1165 0.0091
647 BLOOD PRESSURE FLUCTUATION 218 0.0091
648 DEPRESSION 2060 0.0090
649 ABDOMINAL PAIN UPPER 1862 0.0090
650 COMPLICATION ASSOCIATED WITH DEVICE 131 0.0090
651 NO THERAPEUTIC RESPONSE 110 0.0090
652 EATING DISORDER 192 0.0090
653 BRAIN OEDEMA 113 0.0089
654 BRAIN FOG 140 0.0089
655 CHOLECYSTECTOMY 102 0.0089
656 SKIN DISCOLOURATION 410 0.0089
657 BONE PAIN 522 0.0089
658 INFECTION 1289 0.0089
659 DIALYSIS 126 0.0089
660 STEVENS-JOHNSON SYNDROME 197 0.0089
661 TRANSAMINASES INCREASED 196 0.0088
662 BLOOD GLUCOSE DECREASED 423 0.0088
663 DISORIENTATION 348 0.0088
664 TINNITUS 403 0.0088
665 ISCHAEMIC STROKE 156 0.0087
666 TOXIC SKIN ERUPTION 88 0.0087
667 TREATMENT NONCOMPLIANCE 478 0.0087
668 DRUG INTOLERANCE 843 0.0087
669 OROPHARYNGEAL PAIN 807 0.0087
670 HYPOTONIA 87 0.0087
671 BLISTER 489 0.0087
672 GASTRIC HAEMORRHAGE 100 0.0087
673 NIGHT SWEATS 280 0.0087
674 TOOTH EXTRACTION 108 0.0087
675 HYPERHIDROSIS 1117 0.0087
676 ILLNESS 893 0.0087
677 CHOKING 169 0.0087
678 COLON CANCER 129 0.0086
679 TREMOR 1430 0.0086
680 SLEEP DISORDER 608 0.0086
681 ABDOMINAL DISCOMFORT 1442 0.0086
682 DRUG TOXICITY 117 0.0086
683 ANXIETY 2439 0.0086
684 CEREBROVASCULAR ACCIDENT 1449 0.0085
685 AMNESIA 556 0.0085
686 HAEMORRHAGE 890 0.0085
687 FOOT DEFORMITY 94 0.0085
688 JAUNDICE 227 0.0084
689 IMMUNE SYSTEM DISORDER 111 0.0084
690 LIMB DISCOMFORT 259 0.0084
691 HYPOAESTHESIA 1252 0.0084
692 NODULE 109 0.0083
693 HEADACHE 5234 0.0083
694 MALAISE 3654 0.0083
695 DIPLOPIA 216 0.0083
696 FEMUR FRACTURE 257 0.0083
697 LEUKOPENIA 415 0.0083
698 GASTROINTESTINAL DISORDER 743 0.0083
699 MOBILITY DECREASED 594 0.0083
700 JOINT SWELLING 987 0.0082
701 RHABDOMYOLYSIS 340 0.0081
702 LACRIMATION INCREASED 246 0.0081
703 ASTHMA 920 0.0081
704 BRONCHOSPASM 116 0.0081
705 JOINT RANGE OF MOTION DECREASED 109 0.0081
706 INTERSTITIAL LUNG DISEASE 393 0.0081
707 ERUCTATION 157 0.0081
708 METASTASES TO LIVER 142 0.0081
709 PLATELET COUNT INCREASED 105 0.0080
710 WOUND 225 0.0080
711 EYE PAIN 453 0.0080
712 KNEE ARTHROPLASTY 169 0.0080
713 PAIN 4928 0.0080
714 BASAL CELL CARCINOMA 125 0.0080
715 BLOOD GLUCOSE INCREASED 1504 0.0080
716 LIVER DISORDER 353 0.0080
717 THIRST 142 0.0079
718 FEELING ABNORMAL 1903 0.0079
719 PERITONITIS 164 0.0079
720 SKIN HAEMORRHAGE 117 0.0079
721 IRRITABLE BOWEL SYNDROME 169 0.0079
722 PERIPHERAL COLDNESS 108 0.0079
723 PHARMACEUTICAL PRODUCT COMPLAINT 204 0.0078
724 BLOOD GLUCOSE FLUCTUATION 86 0.0078
725 CONDITION AGGRAVATED 2384 0.0078
726 PALLOR 213 0.0078
727 INSOMNIA 2080 0.0078
728 AGITATION 573 0.0078
729 ARTHROPATHY 433 0.0078
730 HOT FLUSH 587 0.0078
731 GASTRIC DISORDER 267 0.0078
732 SCAR 133 0.0078
733 METASTASES TO CENTRAL NERVOUS SYSTEM 100 0.0077
734 MIGRAINE 740 0.0077
735 INTESTINAL PERFORATION 87 0.0077
736 IMPAIRED HEALING 254 0.0077
737 PRODUCT ADMINISTRATION ERROR 156 0.0077
738 SPINAL OPERATION 95 0.0077
739 PANCREATITIS 407 0.0077
740 HALLUCINATION, VISUAL 162 0.0077
741 MEMORY IMPAIRMENT 1047 0.0076
742 INJECTION SITE EXTRAVASATION 94 0.0076
743 METASTASES TO BONE 125 0.0076
744 LYMPHADENOPATHY 269 0.0076
745 HEPATIC ENZYME INCREASED 516 0.0076
746 NASOPHARYNGITIS 1395 0.0076
747 MYALGIA 1285 0.0076
748 CONJUNCTIVITIS 140 0.0075
749 RASH PRURITIC 409 0.0075
750 EOSINOPHILIA 132 0.0075
751 MUSCLE TIGHTNESS 122 0.0075
752 VISION BLURRED 1033 0.0075
753 APHONIA 105 0.0075
754 NERVOUSNESS 393 0.0075
755 EYE HAEMORRHAGE 100 0.0075
756 SNEEZING 168 0.0075
757 NEOPLASM 86 0.0075
758 HYPOACUSIS 322 0.0075
759 ARTHRALGIA 3091 0.0074
760 OSTEONECROSIS OF JAW 183 0.0074
761 DRUG LEVEL INCREASED 122 0.0074
762 COVID-19 1289 0.0073
763 PROTEINURIA 139 0.0073
764 SWELLING FACE 476 0.0073
765 POOR QUALITY SLEEP 157 0.0073
766 LYMPHOPENIA 103 0.0073
767 FEELING HOT 446 0.0073
768 ROAD TRAFFIC ACCIDENT 304 0.0073
769 DEPRESSED LEVEL OF CONSCIOUSNESS 287 0.0072
770 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 348 0.0072
771 MULTIPLE FRACTURES 119 0.0072
772 PHOTOPHOBIA 136 0.0072
773 SPEECH DISORDER 378 0.0072
774 GAIT INABILITY 238 0.0071
775 INTENTIONAL DOSE OMISSION 202 0.0071
776 PRURITUS GENERALISED 153 0.0071
777 INCREASED APPETITE 135 0.0071
778 CARDIOVASCULAR DISORDER 179 0.0070
779 FEELING JITTERY 134 0.0070
780 CONVULSION 401 0.0070
781 CYST 87 0.0070
782 CEREBRAL INFARCTION 171 0.0070
783 DYSGEUSIA 519 0.0070
784 PHARYNGITIS 86 0.0069
785 VERTIGO 422 0.0069
786 HIP ARTHROPLASTY 106 0.0069
787 PARAESTHESIA 1088 0.0069
788 COGNITIVE DISORDER 322 0.0069
789 HEAD DISCOMFORT 122 0.0069
790 COORDINATION ABNORMAL 96 0.0069
791 CONTRAINDICATED PRODUCT ADMINISTERED 208 0.0069
792 RASH MACULAR 239 0.0068
793 RESTLESSNESS 249 0.0068
794 PRODUCT DOSE OMISSION IN ERROR 192 0.0068
795 THERAPY PARTIAL RESPONDER 105 0.0067
796 DEATH 5781 0.0067
797 HYPOAESTHESIA ORAL 101 0.0067
798 ORAL DISCOMFORT 93 0.0067
799 EYE DISORDER 220 0.0067
800 MALIGNANT NEOPLASM PROGRESSION 684 0.0067
801 PRODUCT DOSE OMISSION 436 0.0067
802 ERYTHEMA 1369 0.0067
803 SWOLLEN TONGUE 207 0.0066
804 MEDICATION ERROR 368 0.0066
805 ALOPECIA 1300 0.0066
806 COLITIS ULCERATIVE 295 0.0066
807 CHROMATURIA 148 0.0065
808 PRESCRIBED UNDERDOSE 130 0.0065
809 HOSPITALISATION 1000 0.0065
810 MUSCLE TWITCHING 150 0.0065
811 BLOOD CREATINE PHOSPHOKINASE INCREASED 187 0.0065
812 MIDDLE INSOMNIA 121 0.0065
813 EYE SWELLING 241 0.0065
814 COMPLETED SUICIDE 539 0.0065
815 NEUROTOXICITY 113 0.0064
816 DEAFNESS 168 0.0064
817 MALIGNANT MELANOMA 86 0.0064
818 BURNING SENSATION 450 0.0064
819 THINKING ABNORMAL 119 0.0064
820 DELUSION 99 0.0064
821 PHARYNGEAL OEDEMA 98 0.0064
822 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 148 0.0063
823 SURGERY 372 0.0063
824 BLOOD GLUCOSE ABNORMAL 117 0.0063
825 RASH ERYTHEMATOUS 301 0.0063
826 SKIN DISORDER 210 0.0063
827 THERAPY INTERRUPTED 449 0.0063
828 ALTERED STATE OF CONSCIOUSNESS 136 0.0063
829 TENDONITIS 97 0.0063
830 RASH 2717 0.0062
831 PRURITUS 2390 0.0062
832 DRY EYE 309 0.0062
833 GLYCOSYLATED HAEMOGLOBIN INCREASED 156 0.0062
834 VISUAL ACUITY REDUCED 205 0.0062
835 BLINDNESS UNILATERAL 87 0.0062
836 MUSCULOSKELETAL STIFFNESS 540 0.0062
837 PRODUCT DOSE OMISSION ISSUE 1808 0.0061
838 PARALYSIS 88 0.0061
839 VISUAL IMPAIRMENT 753 0.0061
840 SKIN FISSURES 118 0.0060
841 INTENTIONAL PRODUCT MISUSE 525 0.0060
842 SKIN CANCER 129 0.0060
843 LOWER RESPIRATORY TRACT INFECTION 269 0.0059
844 ACCIDENTAL OVERDOSE 216 0.0059
845 ABDOMINAL PAIN LOWER 148 0.0058
846 ILL-DEFINED DISORDER 355 0.0058
847 HEPATIC FUNCTION ABNORMAL 218 0.0058
848 JOINT STIFFNESS 153 0.0058
849 NEOPLASM PROGRESSION 202 0.0058
850 BLINDNESS 236 0.0058
851 THROAT TIGHTNESS 155 0.0057
852 EMOTIONAL DISORDER 176 0.0057
853 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 405 0.0057
854 EMOTIONAL DISTRESS 688 0.0057
855 RASH GENERALISED 147 0.0057
856 LIP SWELLING 189 0.0057
857 MUSCULOSKELETAL DISORDER 108 0.0057
858 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 96 0.0056
859 NERVOUS SYSTEM DISORDER 176 0.0056
860 SEIZURE 651 0.0056
861 DYSKINESIA 229 0.0056
862 CYTOMEGALOVIRUS INFECTION 93 0.0056
863 OCULAR HYPERAEMIA 265 0.0056
864 PREMATURE BABY 167 0.0055
865 OFF LABEL USE 4772 0.0054
866 PRODUCT PRESCRIBING ERROR 129 0.0054
867 PANIC ATTACK 197 0.0054
868 SENSORY DISTURBANCE 86 0.0054
869 THERAPEUTIC RESPONSE UNEXPECTED 240 0.0053
870 DIABETIC KETOACIDOSIS 128 0.0053
871 MENTAL IMPAIRMENT 129 0.0053
872 GENERALISED TONIC-CLONIC SEIZURE 88 0.0053
873 PRODUCT USE ISSUE 999 0.0053
874 GLOSSODYNIA 119 0.0053
875 HEPATITIS 136 0.0053
876 TOOTH LOSS 110 0.0053
877 PERICARDITIS 89 0.0053
878 DISCOMFORT 323 0.0053
879 INFLAMMATION 273 0.0053
880 RASH PAPULAR 118 0.0053
881 INTENTIONAL PRODUCT USE ISSUE 459 0.0052
882 SKIN EXFOLIATION 438 0.0052
883 DERMATITIS 108 0.0051
884 INFLUENZA LIKE ILLNESS 424 0.0051
885 MENTAL DISORDER 224 0.0051
886 DISTURBANCE IN ATTENTION 277 0.0051
887 LIVER INJURY 126 0.0051
888 DEVICE DISLOCATION 223 0.0051
889 EYE IRRITATION 295 0.0051
890 THERAPY CESSATION 263 0.0051
891 ORAL HERPES 99 0.0051
892 FRACTURE 96 0.0051
893 EYE PRURITUS 170 0.0051
894 ANAPHYLACTIC REACTION 279 0.0050
895 DRY SKIN 669 0.0050
896 WRONG TECHNIQUE IN DRUG USAGE PROCESS 182 0.0050
897 DRUG-INDUCED LIVER INJURY 156 0.0050
898 HYPERSENSITIVITY 910 0.0049
899 MOVEMENT DISORDER 157 0.0049
900 LUNG NEOPLASM MALIGNANT 200 0.0049
901 RHEUMATOID ARTHRITIS 552 0.0049
902 ABNORMAL DREAMS 134 0.0048
903 DEPRESSED MOOD 254 0.0048
904 SYSTEMIC LUPUS ERYTHEMATOSUS 169 0.0048
905 OSTEONECROSIS 156 0.0047
906 ADVERSE DRUG REACTION 420 0.0047
907 NEOPLASM MALIGNANT 311 0.0047
908 PRESCRIBED OVERDOSE 90 0.0046
909 NIGHTMARE 160 0.0046
910 SEDATION 121 0.0046
911 URTICARIA 770 0.0046
912 DEVICE LEAKAGE 199 0.0046
913 DRUG DOSE OMISSION 754 0.0046
914 IMPAIRED WORK ABILITY 97 0.0045
915 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 814 0.0045
916 VAGINAL HAEMORRHAGE 195 0.0045
917 PRODUCT USE IN UNAPPROVED INDICATION 1111 0.0045
918 DRUG ADMINISTRATION ERROR 137 0.0045
919 PSYCHOTIC DISORDER 128 0.0043
920 CRYING 157 0.0043
921 MYELOSUPPRESSION 155 0.0043
922 TOXICITY TO VARIOUS AGENTS 718 0.0043
923 PRODUCT PHYSICAL ISSUE 85 0.0042
924 UNDERDOSE 307 0.0042
925 ERECTILE DYSFUNCTION 107 0.0042
926 ADVERSE EVENT 381 0.0041
927 DEVICE MALFUNCTION 290 0.0041
928 ANGIOEDEMA 182 0.0041
929 THERAPEUTIC RESPONSE DECREASED 248 0.0041
930 PAIN OF SKIN 110 0.0041
931 BONE DENSITY DECREASED 127 0.0040
932 ECZEMA 208 0.0040
933 IRRITABILITY 239 0.0040
934 DISEASE RECURRENCE 189 0.0040
935 PSORIATIC ARTHROPATHY 157 0.0039
936 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 273 0.0038
937 ABNORMAL BEHAVIOUR 152 0.0038
938 DRUG EFFECT DECREASED 206 0.0038
939 PRODUCT AVAILABILITY ISSUE 87 0.0038
940 MULTIPLE SCLEROSIS 181 0.0038
941 MOOD ALTERED 103 0.0038
942 MULTIPLE SCLEROSIS RELAPSE 258 0.0038
943 TREATMENT FAILURE 306 0.0037
944 THERAPEUTIC PRODUCT EFFECT DECREASED 165 0.0037
945 DEVICE ISSUE 330 0.0037
946 TARDIVE DYSKINESIA 103 0.0036
947 INCORRECT DOSE ADMINISTERED 825 0.0036
948 PANCREATIC CARCINOMA 102 0.0035
949 AGGRESSION 176 0.0035
950 DRUG INEFFECTIVE 4538 0.0034
951 INTENTIONAL OVERDOSE 217 0.0034
952 DEVICE USE ERROR 117 0.0034
953 INJECTION SITE PRURITUS 225 0.0034
954 INCORRECT DRUG ADMINISTRATION DURATION 92 0.0033
955 INJECTION SITE HAEMORRHAGE 258 0.0032
956 NEEDLE ISSUE 93 0.0032
957 OVERDOSE 682 0.0032
958 PRODUCT QUALITY ISSUE 422 0.0031
959 INJECTION SITE BRUISING 247 0.0031
960 INJECTION SITE RASH 93 0.0030
961 INJECTION SITE ERYTHEMA 375 0.0030
962 ANGER 100 0.0030
963 INJECTION SITE MASS 107 0.0029
964 EXTRA DOSE ADMINISTERED 117 0.0029
965 EPILEPSY 87 0.0028
966 INJECTION SITE PAIN 869 0.0028
967 SUICIDAL IDEATION 255 0.0028
968 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 152 0.0028
969 WITHDRAWAL SYNDROME 116 0.0028
970 MATERNAL EXPOSURE DURING PREGNANCY 244 0.0027
971 SUICIDE ATTEMPT 164 0.0027
972 MOOD SWINGS 85 0.0027
973 DRUG EFFECT INCOMPLETE 96 0.0026
974 BREAST CANCER 246 0.0026
975 PSORIASIS 339 0.0026
976 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 502 0.0025
977 PRODUCT SUBSTITUTION ISSUE 136 0.0024
978 SKIN IRRITATION 106 0.0023
979 FOETAL EXPOSURE DURING PREGNANCY 188 0.0023
980 DEVICE BREAKAGE 93 0.0023
981 INJECTION SITE REACTION 147 0.0021
982 EXPOSURE DURING PREGNANCY 132 0.0021
983 INJECTION SITE SWELLING 160 0.0021
984 DERMATITIS ATOPIC 107 0.0020
985 DRUG WITHDRAWAL SYNDROME 176 0.0020
986 SKIN BURNING SENSATION 121 0.0017
987 ACNE 127 0.0017
988 PROSTATE CANCER 133 0.0017
989 NO ADVERSE EVENT 280 0.0015
990 DEVICE DIFFICULT TO USE 101 0.0015
991 DRUG ABUSE 115 0.0014
992 DRUG DEPENDENCE 205 0.0013
993 ACCIDENTAL EXPOSURE TO PRODUCT 130 0.0013
994 PRODUCT STORAGE ERROR 95 0.0011